drugset / Trial / NCT07532577
Intranasal Insulin to Prevent Intensive Care Unit Delirium
RandomizedParallel-groupQuadruple-blindPrevention
Summary
This study aims to assess the feasibility, tolerability, and exploratory efficacy of intranasal insulin to prevent delirium in ICU patients aged ≥65 years after complex elective cardiac surgery with cardiopulmonary bypass
Timeline
- Start
- 2026-04-15
- Primary completion
- 2026-07-15
- Completion
- 2026-08-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Insulin | Protein / enzyme biologic | 20 iu | Intranasal |